(2R,3S)-2-{(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY}-3-(4-FLUOROPHENYL)MORPHOLINE HYDROCHLORIDE Cas:171482-05-6

We are (2R,3S)-2-{(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY}-3-(4-FLUOROPHENYL)MORPHOLINE HYDROCHLORIDE CAS:171482-05-6 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Product Description:

Product Name:

(2R,3S)-2-{(1R)-1-[3,5-BIS(TRIFLUOROMETHYL)PHENYL]ETHOXY}-3-(4-FLUOROPHENYL)MORPHOLINE HYDROCHLORIDE CAS NO: 171482-05-6

 

Synonyms:

(2R,3S)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)Morpholine hydrochloride (1:1);

Aprepitant HCl;

Aprepitant M2 Metabolite (1R, 2R, 3S);

 

Chemical & Physical Properties:

Appearance: White to off-white solid

Assay :≥99.00%

Boiling Point: 387.9℃ at 760 mmHg

Flash Point: 188.4℃

 

5-[[(2R, 3S) -2-[(1R) -1-[3, 5-bis (trifluoromethyl) phenyl] ethoxy]-3- (4-fluorophenyl) -4-morphoryl] methyl]-1, 2-dihydro-3H-1, 2, chemicalbook4-triazol-3-ketone It is an antiemetic drug developed by Merck in the United States for the prevention of acute and delayed vomiting during chemotherapy. Clinical studies have shown that adjuvant administration of aprepitant can significantly control chemotherapy-induced nausea and vomiting (CINV) symptoms in the use of moderate and highly emetic chemotherapy drugs.

 

If you are interested in our products or have any questions, please feel free to contact us!

 

Products under patent are offered for R & D purpose only. However, the final responsibility lies exclusively with the buyer.

Related Products:2-amino-4-(3,4-dimethoxyphenyl)butanoic acid manufacturer | 1,6-dimethyl-3,8-diphenyl-1,2,4,6,7,9-hexaza-5λ⁵-phosphaspiro[4.4]nona-2,4,8-triene supplier | 9,10-Dihydro-1,9-dimethyl-3,5,7-triphenyl-1H-1,3,2λ5,4-diazadiphospheto<2,1-c:2,3-c’>bis(1,2,4,3λ5-triazaphosphol)-10-amin-5-oxid producer.